TrialLung2023

Efficacy and Safety of Eliapixant in Refractory Chronic Cough: The Randomized, Placebo-Controlled Phase 2b PAGANINI Study.

Peter V Dicpinigaitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.